The U.S. Food and Drug Administration (FDA) has approved ranibizumab injection (Susvimo, 100 mg/mL; Genentech) for the ...
Data from phase 3 trials of the drug in diabetic macular oedema (DMO) provide some encouragement ... when it came to inflammatory reactions in the eye. Earlier this year, Novartis halted three ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback